| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
5e-08 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-07 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
7e-07 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-06 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.23 |
3e-06 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-06 |
| mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.21 |
8e-06 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
8e-05 |